Biocept Stock Price - BIOC

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Last Trade
Last $ 0.31 ▲ 0.00 (0.32%)
Company Name Stock Ticker Symbol Market Type
Biocept Inc BIOC NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.309 0.00 0.00 0.00 0.309 08:32:44
Bid Price Ask Price Spread Spread % News
0.306 0.311 0.005 1.61% - -
Stock Trades Traded Volume Average Volume 52 Week Range
13 22,071 10,024,166 0.2275 - 2.50
Last Trade Time Type Quantity Stock Price Currency
08:32:43 formt 500 $ 0.31 USD

Biocept Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 13.05M 42.22M $ -24.57M -9.19 - 41.66M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Biocept News

Loading Messages....

Latest BIOC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIOC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.360.3650.28140.33615273,019,672-0.051-14.17%
1 Month0.28350.490.2740.347271312,749,9460.02558.99%
3 Months0.700.74740.22750.33270816,398,906-0.391-55.86%
6 Months1.021.150.22750.36813,049,622-0.711-69.71%
1 Year2.202.500.22750.84827083,046,598-1.89-85.95%
3 Years1.5512.150.1411.091,809,977-1.24-80.06%
5 Years2.3212.150.1411.531,520,719-2.01-86.68%

Biocept Description

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.